Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.880
-0.100 (-3.36%)
At close: Aug 7, 2025, 4:00 PM
2.980
+0.100 (3.47%)
Pre-market: Aug 8, 2025, 8:24 AM EDT

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019 - 2020
184573535
Upgrade
Market Cap Growth
-28.05%-13.25%-30.09%-79.64%0.50%-
Upgrade
Enterprise Value
161-222932
Upgrade
Last Close Price
2.886.6922.92258.721493.186332.48
Upgrade
PS Ratio
5.40233.5833.9320.5072.86-
Upgrade
PB Ratio
13.58-8.96-22.19-2.831.5811.61
Upgrade
P/TBV Ratio
27.24---1.5811.61
Upgrade
EV/Sales Ratio
16.0750.81-6.3560.68-
Upgrade
Debt / Equity Ratio
0.14-0.27-0.90-0.100.010.12
Upgrade
Asset Turnover
0.210.010.030.020.03-
Upgrade
Quick Ratio
0.890.280.550.464.121.56
Upgrade
Current Ratio
1.030.660.860.664.301.62
Upgrade
Return on Equity (ROE)
-714.97%---301.42%-197.66%-27822.18%
Upgrade
Return on Assets (ROA)
-176.75%-180.62%-208.63%-106.50%-84.78%-270.89%
Upgrade
Return on Capital (ROIC)
-433.26%---184.48%-121.74%-2921.10%
Upgrade
Earnings Yield
-73.64%-170.95%-375.53%-414.34%-70.90%-69.20%
Upgrade
FCF Yield
-64.42%-197.85%-425.56%-387.18%-64.01%-44.75%
Upgrade
Buyback Yield / Dilution
-421.07%-404.96%-425.71%---
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q